Episode 153 · Impact · 63 min

Incentives before invention

Social Alpha has backed more than 350 science startups in nine years, and its founder's first move is to reject the label — none of it was about deep tech, it was about the problems no capital pool will touch. Manoj Kumar's claim is that inventions stall not for want of money but for want of aligned incentives, and that philanthropy is the third power that has to pay for the stretch between a lab bench and a smallholder's field.

MK
Manoj Kumar
Founder, Social Alpha · with Vishal Krishna
Incentives before invention — episode thumbnail
1:02:45
Said in this episode
▶ 0:29
350+
Companies Social Alpha has supported
The host's figure, repeated twice and unchallenged, over roughly nine years — though Manoj insists deep tech is 'not a VC numbers game' and that only a fraction go the distance.
▶ 12:20
5
Incubators built, then let go
The first was funded jointly by the Government of India and Tata Trusts, with Mr Tata then chairing the Trusts; the rest came with other partners. None of those partners fund them today — the incubators are self-sustaining.
▶ 35:50
6–7 yrs
Cohort to exit, cold-chain startup
An IIT Madras phase-change-material company joined the first accelerator cohort via a clean-energy challenge; Social Alpha piloted, invested and has now exited, recycling the proceeds.
▶ 29:53
₹50 → ₹60
The proof a farmer actually needs
Manoj's illustration of demonstrating value: the same argument you make to a corporate about shareholder value, expressed to a farmer as income this year versus next.
▶ 53:22
3
Sodium-ion battery companies backed
Deliberately not an EV play. India has no lithium security, so the bet is a portfolio of chemistries across stationary, mobility and small-format use cases — and the search is still active.
▶ 1:00:20
6%
The safe end of the risk continuum
Bank deposit interest, cited as the anchor of a continuum that runs through government bonds, private equity and VCs to Social Alpha, which funds products before they exist.
The brief

The argument in sixty seconds

Manoj Kumar's first move is to reject the label the episode was booked under: Social Alpha was never about deep tech, it was about the problems — waste, plastic pollution, post-harvest loss, primary-care diagnostics — that cannot be solved without science and that no market will pay to solve. His claim is that Indian innovation fails not at invention but in the gap between the lab and the community, and that the gap has three parts, not one: development, de-risking and deployment. Government is the biggest funder of Indian science and is badly overextended; industry will do what serves its shareholders, and for a smallholder farmer there is no industry at all. That leaves philanthropy as what he calls the third power — the money willing to buy the risk between a working prototype and an investable company. Around that sits his operating theory: collaboration is a nice English word that means nothing until incentives are aligned, so his real job is orchestration — a foundation funds product development, a family office co-invests, a state government unlocks subsidies for market creation. Social Alpha writes the first cheque itself, because calling a company investable without skin in the game convinces nobody, then exits when the founders no longer need it and recycles the money. Nine years, five incubators and 350-odd companies in, the biggest mistake he admits to is the one he started with — assuming it was a money problem.

Worth your time if you are

Researchers sitting on a patent with no path to market
Foundation and CSR teams deciding what to fund next
Deep-tech founders in Tier-2 towns without a VC network
Impact investors pricing risk against return
Policy people building translational research capacity
Episode map

Where the conversation travels

Every block is a chapter, coloured by what it's about. Click any of it to jump straight to that minute on YouTube.

01Cold open: 350 companies, nine years 0:00 Vishal introduces a guest who is somehow accelerator, incubator, fund and philanthropy at once, and notes that Manoj left private equity to bet a decade on Indian deep tech. 02It was never about deep tech 1:45 Manoj reframes the premise: the work started from tough problems — waste management, plastic pollution, smallholder inputs and post-harvest loss, out-of-pocket diagnostics that push families to moneylenders — and those problems simply cannot be solved without science. 03Development, de-risking, deployment 4:50 Product people think only about development, but a lab-to-market innovation needs de-risking on two fronts at once — for the end user's price, access and experience, and for the capital pools that come next — before deployment is even possible. 04Magic happens on the intersections 7:50 Working at the junction of science, societal need and entrepreneurial risk multiplies the impact but multiplies the stakeholders too, and none of them move unless the innovator, the farmer, the government and the investor each see value. 05Tata Trusts, five incubators and a balance sheet 11:05 What began as a hobby project became five incubators funded by the Government of India, Tata Trusts and others — with Gates, IKEA and H&M foundations plus Pfizer and Cisco CSR behind the programmes — while investment capital had to come off Social Alpha's own balance sheet and government seed schemes. 06Partnership is the crux 17:10 Closing the loop from lab to community means simultaneous partnerships with the R&D system, with co-investors, with grassroots NGOs who can actually run pilots, and with central and state governments — each one built so the partner gets value too. 07The missing floor: translational research 20:30 India has a strong publicly funded research base, but going from a one-litre lab experiment to a hundred-litre run needs translational infrastructure, skills and intent — and a willingness to spin off companies that capital can then back. 08Philanthropy as the third power 24:10 Government works within public-finance limits and industry within shareholder logic, so philanthropy is the third power that must fund innovations into investment-readiness — the way it once built IISc and TIFR, and the way India's family offices could again. 09Fragmentation is the opportunity 27:40 Rather than blame seed sellers or tractor firms for ignoring smallholder livelihoods, Manoj argues you demonstrate value first — show a farmer this year's ₹50 becomes ₹60 — and treat India's agro-climatic and epidemiological diversity as a set of markets, not an obstacle. 10The MRI founder who kept going 31:00 Deep-tech founders carry innovation, investment, social and business risk simultaneously — as with Arjun, who left academia to build an affordable MRI, prototyped in a Whitefield hospital, lost trial time to COVID, ran out of money repeatedly and has only now cleared Indian regulatory approval against GE, Philips and Siemens. 11Labs, Ventures, Community 35:30 The three-part architecture explained — Labs for zero-to-one prototyping with physical facilities in Delhi and Bangalore, Ventures for market de-risking where Social Alpha writes the first cheque as skin in the game, and Community for large-scale deployment. 12Foundations, ego and the mistakes 39:30 Raising from foundations is the same incentive-alignment problem in another costume, ego has no place in the queue for social capital, and the biggest mistake was assuming that if VCs would not invest, Social Alpha's own cheques would fix it. 13Phase-change boxes and small-town engineering 44:40 A PhD-thesis phase-change material first piloted on UP farmers' produce now keeps ice cream cold in urban food delivery, while a Manipal team's backpack vaccine carrier heads to Africa and an Udaipur bio-polymer that cuts irrigation need has moved to Japan. 14Money as outcome, not objective 48:20 Not every startup is a unicorn and money should be the pleasant consequence of solving a real problem, not the point — a conviction Manoj holds while calling the next two or three years a search for a repeatable playbook. 15Sodium-ion, biogas boxes, bloodless screening 52:40 The forward book: a portfolio of battery chemistries because India has no lithium security, new materials, non-invasive village-level screening an ASHA worker could run, and the unanswered question of why nobody has productised biogas into a box you can buy. 16Calvin, Taleb and the risk continuum 58:50 The close turns on risk as a continuum — bank deposits at one end, VCs in the middle, Social Alpha at the far end funding products that do not exist yet — with Taleb's skin in the game and a pilot-versus-consultant analogy for the punchline.
Takeaways

Ideas to carry out of this hour

01

It was never about deep tech

Asked to talk about deep tech, Manoj corrects the frame within a minute: the work started from problems, not technologies. Waste management, plastic pollution, smallholder farm equipment and post-harvest loss, primary healthcare where out-of-pocket diagnostics send families to moneylenders and manufacture intergenerational poverty. Deep tech is simply what those problems require. The tell is the funding asymmetry he draws: a new fabric or a new drug molecule reaches market fast because the ecosystem exists, but a low-cost cervical-cancer screening device has no such ecosystem — outside government, nobody funds it.

02

Development is only one third of the job

Science teams think in terms of development — build the thing — and stop there. Manoj's structure adds two more Ds. De-risking runs on two tracks simultaneously: for the end user, meaning affordability, accessibility, user experience and a reason to pay; and for capital, meaning the company becomes legible to the next investor. Deployment then requires somebody to physically go where the user is and make adoption happen. Invention, in his telling, confers no right to a market.

03

Collaboration is a nice English word; incentives are the job

He says it twice, unprompted, in different halves of the conversation: collaboration sounds good but does not happen unless incentives align. The farmer, the innovator, the government and the investor each act only on visible value, and every pair may transact happily while the whole coalition never forms. Orchestrating that — a foundation funding product development, an investor entering later, a government unlocking subsidies for market creation — is the actual product Social Alpha sells. And incentive, he stresses, need not be financial: recognition, mission and happiness all count, so long as you know which one is operating.

04

Philanthropy is the third power

Government is India's largest funder of science and, precisely because of that, overextended across too many demands. The private sector will do what serves shareholders, and for a smallholder farmer there is no private sector at all — the only route is spinning off a startup. That leaves philanthropy as the third power, the money that can carry an innovation from lab to investment-ready. He points out that India already did this once: IISc and TIFR were built with philanthropic money under British rule, by the Maharaja of Mysore and the Tatas. The money exists again, in family offices and HNI pockets; the habit has lapsed.

05

If you call a company investable, write the first cheque

Social Alpha's principle is that declaring a startup investment-ready means nothing coming from a party with nothing at stake. So when the Ventures stage concludes a company is investable, Social Alpha invests first, then takes that diligence to co-investors and family offices such as Rainmatter. Some join the round; some ask to come back in a year for more traction, which becomes the next pilot programme. Being not-for-profit, exits do not distribute — an exit from an early cold-chain company returned capital that was recycled straight into new ones.

06

Demonstrate value before you argue about willingness to pay

The standard line is that farmers will not pay. Manoj's reply is a question: have you tried showing them value? Every consumer pays when value is visible, and the demonstration for a farmer is the same arithmetic as for a corporate — this year you made ₹50, next year you will make ₹60. He extends the point to India's fragmentation, which he refuses to treat as a defect: multiple agro-climatic zones, soils, food cultures and epidemiological profiles mean a cookie-cutter product fails, and each cluster of problems is itself a large market.

07

The mistake was assuming it was a money problem

The founding hypothesis was simple: VCs are not writing cheques into these companies, so we will. He now calls that naive. VCs stay out for a reason — a fiduciary duty to LPs and no return commensurate with the risk — and money turns out to be one piece of a jigsaw that also contains market development, policy advocacy, testing, pilots and, first of all, whether the right problem was chosen. Five years of R&D can produce a great product nobody wants to pay for. His other admitted errors are managerial: hiring badly, and then not firing, because he told himself the social sector required him to be nicer.

08

The map of Indian deep tech runs through Manipal and Udaipur

Put the portfolio on a map of India and the startups are not clustered in Bangalore, Bombay, Madras and Delhi. A Manipal company built a backpack vaccine carrier now being deployed in Africa, with the Manipal family office invested. A team of engineers from Udaipur made a bio-polymer that raises soil moisture retention so irrigation — and its cost — falls; it has since incorporated in Japan with Japanese investors, after a first pilot in drought-hit Bundelkhand. Founders from Jodhpur, Kanpur and lesser-known colleges are, in his words, sometimes weak at PowerPoint and English and very strong at engineering.

The numbers, drawn

What the episode measures

Every figure below was said on air — timestamps included, caveats kept.

Conversation share

portion of the hour spent on each theme
Impact & outcomes · 22%Deep tech & hardware · 20%Venture capital · 15%Supply chain & agri · 12%Healthcare · 10%Climate & energy · 8%
Impact & outcomes22%
Deep tech & hardware20%
Venture capital15%
Supply chain & agri12%
Healthcare10%
Climate & energy8%
Computed from the chapter map of this episode.

How long deep tech actually takes

years
Cohort to exit, cold6.5Building the product8A full lab-to-market12.5
All three figures as spoken on air: 'six, seven years... six years down the line we just had an exit' for the IIT Madras cold-chain company (plotted at 6.5); 'you spend 8 years of your life building a product'; and 'sometimes a 10, 15 year journey' (midpoint plotted). Illustrative of Manoj's argument about patience, not a measured average.▶ 31:35
Worth keeping

Lines that stay

A lot of people tell me collaboration is the key. I say collaboration is a nice word in English — but collaboration doesn't happen if incentives are not aligned.

— Manoj Kumar ▶ 18:58

Philanthropy is the third power, after government and the private sector.

— Manoj Kumar ▶ 24:49

People say farmers don't want to pay. I ask them: have you tried providing them value? Every consumer is willing to pay — but people pay when they see value.

— Manoj Kumar ▶ 29:33

In my older days I used to do all that. Now I don't give up till I'm thrown out of the office.

— Manoj Kumar ▶ 40:56

An airline pilot has much higher skin in the game flying a plane than a McKinsey consultant advising a company.

— Manoj Kumar ▶ 1:01:40
Clips that travel

Short on time? Start here

Researchers with a prototype and no path to market

Development, de-risking, deployment

The three-part frame that organises the whole episode — and why de-risking has to run for the end user and the investor at the same time.

4:50 → 7:50 · 3 min ▶ Watch clip
Foundation and CSR teams deciding what to fund next

Philanthropy is the third power

The cleanest statement of the capital thesis, plus the reminder that IISc and TIFR were philanthropy-funded before independence.

24:10 → 27:40 · 4 min ▶ Watch clip
Deep-tech founders weighing a long build

The MRI that took a decade

Four kinds of risk carried at once, told through a founder who left academia, lost trial time to COVID and ran out of money repeatedly.

31:00 → 35:30 · 4 min ▶ Watch clip
Impact investors designing a de-risking pipeline

Labs, Ventures, Community — and the first cheque

The operating architecture in the guest's own words, including why Social Alpha invests before it asks anyone else to.

35:30 → 39:30 · 4 min ▶ Watch clip
Anyone who thinks Indian deep tech is a metro story

Ice cream, vaccine backpacks and Udaipur polymers

A phase-change material built for farm produce ending up in food-delivery boxes, and portfolio companies out of Manipal, Udaipur and Jodhpur.

44:40 → 48:20 · 4 min ▶ Watch clip
Glossary

The jargon, unpacked

De-risking
The middle stage between building and deploying an innovation — proving price, user experience, pilots and market size until the company becomes legible to the next pool of capital.
Translational research
The work of turning a lab result into something with tangible value — scaling a one-litre experiment to a hundred litres, for instance — which Manoj argues India under-invests in relative to basic research.
CSR funding
Corporate social responsibility money, which Indian companies deploy into social programmes; Pfizer backed Social Alpha's healthcare programme and Cisco its agriculture programme.
Phase change material
A substance that absorbs or releases heat as it changes state, used to line boxes so produce, vaccines or ice cream stay cold without a powered refrigerator.
ASHA worker
An Accredited Social Health Activist — India's village-level frontline health worker, the operator Manoj wants non-invasive screening devices designed for.
Sodium-ion battery
A battery chemistry using sodium instead of lithium, attractive to Manoj precisely because India has no domestic lithium security.
Skin in the game
Taleb's idea, and Social Alpha's investing rule: your advice counts only if you bear the consequences of it — hence writing the first cheque into any company it calls investable.
Connections

If this resonated, go here next

Full transcript

The whole conversation, searchable

244 segments

Auto-generated captions, lightly cleaned. Click a timestamp to open that moment on YouTube.